Summary

Viral respiratory infections can have overlapping symptoms. Therefore, diagnostic testing is essential to prescribe the appropriate antimicrobial treatment. This webinar will discuss the pre-analytical factors for influenza, respiratory syncytial virus (RSV), and COVID-19, and diagnostic options available. It will give a better understanding of risk groups and what tests need to be focused on particular populations.

Learning Objectives

1. Discuss the current state of COVID-19, influenza, and RSV.
2. Review the current methods to test for viral respiratory pathogens.
3. Define how diagnostic stewardship programs and testing algorithms can help
   determine what tests to use on various patient populations at different times of year.

Matthew J. Binnicker, Ph.D., D(ABMM)
Chief Scientific Officer, Mayo Collaborative Services
Mayo Clinic
Rochester, Minnesota, USA

Dr. Matt Binnicker is the Chief Scientific Officer for Mayo Collaborative Services, which is Mayo Clinic’s outreach diagnostics business. Prior to his current role, Dr. Binnicker served as the director of Clinical Virology at Mayo Clinic. Dr. Binnicker’s lab was one of the first in the United States to develop a molecular test for COVID-19, and he has served as an advisor to multiple Fortune 500 companies on safety protocols and testing recommendations for COVID-19 and respiratory viruses. Dr. Binnicker is a Professor of Laboratory Medicine and Pathology, and he is a past-President of the Pan American Society for Clinical Virology.

Who Should Watch

Laboratory Supervisors, Laboratory Directors (and/or Assistant Directors), Laboratory Managers (Supervisory and/or Non-Supervisory), Medical Technologists, Point-of-Care Coordinators, Other HCPs